Pharmaceutical industry payments to healthcare professionals (May 2016-Apr 2017)

Abstract

About the project This project stems from the Evidence, Policy and Influence Collaborative, led by Prof Lisa Bero, which seeks to translate rigorous and unbiased evidence into clinical practice and health policy. One facet of this Collaborative is the study of bias in healthcare: we sought to understand the extent of pharmaceutical industry marketing in the form of payments to health professionals as a means to begin tracing the influence of marketing on clinical care. About the dataset This dataset contains details of the payments received by Health Professionals in Australia from the pharmaceutical industry from May 2016 to April 2017. Data were accessed on 2 and 27 September 2017 from openly available individual member company reports that were hyperlinked from the Medicines Australia website: https://medicinesaustralia.com.au/code-of-conduct/transparency-reporting/payments-to-healthcare-professionals/member-company-reports/ Related data from the Evidence, Policy and Influence Collaborative Pharmaceutical industry-funded events for Australian health professionals (Oct 2011-Sept 2015): https://dx.doi.org/10.4227/11/592631edbd9d5